Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study.
BMJ Open
; 9(9): e030930, 2019 09 20.
Article
in En
| MEDLINE
| ID: mdl-31542758
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Dexamethasone
/
Macular Edema
/
Health Care Costs
/
Angiogenesis Inhibitors
/
Receptors, Vascular Endothelial Growth Factor
/
Vascular Endothelial Growth Factor A
/
Diabetic Retinopathy
/
Drug Implants
/
Ranibizumab
Type of study:
Etiology_studies
/
Health_economic_evaluation
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
BMJ Open
Year:
2019
Document type:
Article
Country of publication: